Home » Authors » Kamron Fariba, MD

Kamron Fariba, MD

Articles

ARTICLES

Research Update

Marginal Results for Levetiracetam in Mania

April 14, 2023

Kamron Fariba, MD

Kamron Fariba, DO. Dr. Fariba has no financial relationships with companies related to this material.

This anticonvulsant makes its randomized-controlled debut in bipolar mania.

A Single Prescriber Reduces Risk of Overdose in Patients on Opioid and Benzodiazepine

September 25, 2022

Kamron Fariba, MD

Kamron Fariba, MD. Dr. Fariba, author of this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

This large study suggests a practical solution to reduce mortality in patients who are taking both benzodiazepines and opioids.

Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Hospital Psychiatry Fact Book, First Edition (2025) - Spiral Bound
This comprehensive guide is designed to be a valuable resource for professionals working in...
READ MORE

General Psychiatry
KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything
Read More

General Psychiatry
Should You Test MTHFR?
MTHFR is a...
Listen now

Join Our Writing Team
July 18, 2024
Insights About a Rare Transmissible Form of Alzheimer's Disease
February 9, 2024
How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners
May 24, 2024

Join Our Writing Team
July 18, 2024
Insights About a Rare Transmissible Form of Alzheimer's Disease
February 9, 2024
How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners
May 24, 2024

Join Our Writing Team
July 18, 2024
Insights About a Rare Transmissible Form of Alzheimer's Disease
February 9, 2024
How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners
May 24, 2024

Kamron Fariba, MD

ARTICLES

Marginal Results for Levetiracetam in Mania

A Single Prescriber Reduces Risk of Overdose in Patients on Opioid and Benzodiazepine

Hospital Psychiatry Fact Book, First Edition (2025) - Spiral Bound

KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

Should You Test MTHFR?

Join Our Writing Team

Insights About a Rare Transmissible Form of Alzheimer's Disease

How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

Join Our Writing Team

Insights About a Rare Transmissible Form of Alzheimer's Disease

How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

Join Our Writing Team

Insights About a Rare Transmissible Form of Alzheimer's Disease

How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

About

Shop Online

Newsletters

Contact

Follow Us